Literature DB >> 25458655

Is mechanical dyssynchrony a therapeutic target in heart failure with preserved ejection fraction?

Aymeric Menet1, Lorraine Greffe1, Pierre-Vladimir Ennezat2, François Delelis1, Yves Guyomar1, Anne Laure Castel1, Aurélie Guiot1, Pierre Graux1, Christophe Tribouilloy3, Sylvestre Marechaux4.   

Abstract

BACKGROUND: Previous studies have found a high frequency of mechanical dyssynchrony in patients with heart failure (HF) with preserved ejection fraction (HFpEF), hence suggesting that cardiac resynchronization therapy (CRT) may be considered in HFpEF. The present study was designed to compare the amount of mechanical dyssynchrony between HFpEF patients and (1) HF with reduced EF (HFrEF) patients with an indication for CRT (HFrEF-CRT(+)) group, (2) HFrEF patients with QRS duration < 120 ms (HFrEF-QRS < 120 ms) group, and (3) hypertensive controls (HTN).
METHODS: Electrical (ECG) and mechanical dyssynchrony (atrio-ventricular dyssynchrony, interventricular dyssynchrony, intraventricular dyssynchrony) were assessed using conventional, tissue Doppler, and Speckle Tracking strain echocardiography in 40 HFpEF patients, 40 age- and sex-matched HTN controls, 40 HFrEF-QRS < 120 ms patients, and 40 HFrEF-CRT(+) patients.
RESULTS: The frequency of left bundle branch block was low in HFpEF patients (5%) and similar to HTN controls (5%, P = 0.85). Indices of dyssynchrony were similar between HFpEF and HTN patients or HFrEF-QRS < 120 ms patients. In contrast, most indices of dyssynchrony differed between HFpEF and HFrEF-CRT(+) patients. The principal components analysis on the entire cohort of 160 patients yielded 2 homogeneous groups of patients in terms of dyssynchrony, the first comprising HFrEF-CRT(+) patients and the second comprising HTN, HFrEF-QRS < 120 ms and HFpEF patients.
CONCLUSIONS: Mechanical dyssynchrony in HFpEF does not differ from that of patients with HTN or patients with HFrEF and a narrow QRS. This data raises concerns regarding the role of dyssynchrony in the pathophysiology of HFpEF and thereby the potential usage of CRT in HFpEF.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25458655     DOI: 10.1016/j.ahj.2014.08.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  [New therapy concepts for heart failure with preserved ejection fraction].

Authors:  C Tschöpe; B Pieske
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

2.  Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.

Authors:  Tor Biering-Sørensen; Sanjiv J Shah; Inder Anand; Nancy Sweitzer; Brian Claggett; Li Liu; Bertram Pitt; Marc A Pfeffer; Scott D Solomon; Amil M Shah
Journal:  Eur J Heart Fail       Date:  2017-03-21       Impact factor: 15.534

3.  Myocardial work is a predictor of exercise tolerance in patients with dilated cardiomyopathy and left ventricular dyssynchrony.

Authors:  Florian Schrub; Frédéric Schnell; Erwan Donal; Elena Galli
Journal:  Int J Cardiovasc Imaging       Date:  2019-09-12       Impact factor: 2.357

4.  Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: A systematic review and meta-analysis.

Authors:  Theodora Nikolaidou; Nathan A Samuel; Carl Marincowitz; David J Fox; John G F Cleland; Andrew L Clark
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-10-11       Impact factor: 1.468

5.  Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis.

Authors:  Daniel Armando Morris; Xin-Xin Ma; Evgeny Belyavskiy; Radhakrishnan Aravind Kumar; Martin Kropf; Robin Kraft; Athanasios Frydas; Engin Osmanoglou; Esteban Marquez; Erwan Donal; Frank Edelmann; Carsten Tschöpe; Burkert Pieske; Elisabeth Pieske-Kraigher
Journal:  Open Heart       Date:  2017-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.